Roundtable on Patient Safety and Hospital Compounding

Question Title

* 1. Your Information

Name

Company/Organization

Email Address

Question Title

* 2. How are you or your organization involved with the issue of hospital sterile compounding?

Patient safety expert/organization

Hospital policy or advocacy organization

Pharmacist

Prescriber/caregiver or prescriber organization

Pharmacist advocacy/policy organization

Manufacturer of pharmaceutical products and/or compounding devices

Other (please specify)

Question Title

* 3. What changes do you believe have been effective in boosting the safety of sterile compounding in the last 5 years? Answer all that apply.

Federal legislative and/or regulatory changes (please describe)

State regulatory or other policy changes (please describe)

Technology (please describe)

Other or None (please describe)

Question Title

* 4. Please indicate your views on the current strength of:

	Weak	Moderate	Strong
Federal enforcement of compounding sterility guidelines/policy	Federal enforcement of compounding sterility guidelines/policy Weak	Federal enforcement of compounding sterility guidelines/policy Moderate	Federal enforcement of compounding sterility guidelines/policy Strong
State enforcement of compounding sterility guidelines/policy	State enforcement of compounding sterility guidelines/policy Weak	State enforcement of compounding sterility guidelines/policy Moderate	State enforcement of compounding sterility guidelines/policy Strong
Self-regulation among compounding pharmacy facilities	Self-regulation among compounding pharmacy facilities Weak	Self-regulation among compounding pharmacy facilities Moderate	Self-regulation among compounding pharmacy facilities Strong
Implementation of technologies and procedures in hospital environments to improve patient safety related to the use of compounded therapies	Implementation of technologies and procedures in hospital environments to improve patient safety related to the use of compounded therapies Weak	Implementation of technologies and procedures in hospital environments to improve patient safety related to the use of compounded therapies Moderate	Implementation of technologies and procedures in hospital environments to improve patient safety related to the use of compounded therapies Strong

Question Title

* 5. List up to three changes in policy or practice that you believe have had the most beneficial impact on patient safety in the aftermath of the NECC incident (within last 5 years)?

Question Title

* 6. If you are in the healthcare setting, please describe any changes your organization has adopted in the last 5 years to improve the safety of sterile compounding?

Question Title

* 7. Do you believe that there are best practices among hospitals for compounding of patient therapies that are…

Standardized? If no, please explain

Broadly recognized? If no, please explain

Adopted uniformly? If no, please explain

Question Title

* 8. Please select the statement that best reflects your views:

Question Title

* 9. What would you say are currently considered best practices for patient safety related to sterile compounding (check the top three):

Existing state accreditation / certification procedures

Use of pre-mix where available instead of compounded preparations

Deployment and use of new technologies to assist in compounding products

Improved care team communications

Improved prescriber awareness

Centralization of outsourced compounding suppliers for hospital systems

Hospital efforts to bring more sterile compounding in-house

Other

Question Title

* 1. Your Information

Question Title

* 2. How are you or your organization involved with the issue of hospital sterile compounding?

Question Title

* 3. What changes do you believe have been effective in boosting the safety of sterile compounding in the last 5 years? Answer all that apply.

Question Title

* 4. Please indicate your views on the current strength of:

Question Title

* 5. List up to three changes in policy or practice that you believe have had the most beneficial impact on patient safety in the aftermath of the NECC incident (within last 5 years)?

Question Title

* 6. If you are in the healthcare setting, please describe any changes your organization has adopted in the last 5 years to improve the safety of sterile compounding?

Question Title

* 7. Do you believe that there are best practices among hospitals for compounding of patient therapies that are…

Question Title

* 8. Please select the statement that best reflects your views:

Question Title

* 9. What would you say are currently considered best practices for patient safety related to sterile compounding (check the top three):

Question Title

* 10. Broadly speaking, what do you consider the greatest current challenges to sterile compounding for hospital patients? Please list up to three.